Briacell Therapeutics CORP. (BCTXZ) — SC 13D/A Filings
All SC 13D/A filings from Briacell Therapeutics CORP.. Browse 4 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (4)
-
L5 Capital Inc. Amends BriaCell Therapeutics Stake
— Dec 12, 2024 Risk: medium
L5 Capital Inc. filed an amendment (No. 4) to its Schedule 13D on December 12, 2024, regarding its holdings in BriaCell Therapeutics Corp. The filing indicates -
L5 Capital Inc. Amends BriaCell Therapeutics Stake
— Dec 10, 2024 Risk: medium
L5 Capital Inc. filed an amendment (No. 3) to its Schedule 13D on December 10, 2024, regarding its holdings in BriaCell Therapeutics Corp. The filing indicates -
L5 Capital Inc. Amends BriaCell Therapeutics Stake
— Dec 5, 2024 Risk: medium
L5 Capital Inc. filed an amendment (No. 2) to its Schedule 13D on December 5, 2024, regarding its holdings in BriaCell Therapeutics Corp. The filing indicates a -
L5 Capital Inc. Amends BriaCell Therapeutics Stake Filing
— May 24, 2024 Risk: medium
L5 Capital Inc. filed an amendment (No. 1) to its Schedule 13D on May 24, 2024, regarding its holdings in BriaCell Therapeutics Corp. The filing indicates a cha
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX